| Dear Reader, Imagine knowing the exact day a stock could soar. For this company that date could be August 13, 2024. This biotech is pioneering groundbreaking drugs. There is literally nothing else on the market like it. Which is why the FDA could give this company a 12 year exclusivity deal for this treatment, once they give the final greenlight. And with a market expected to grow to $748 million by 2032, the potential for profit for this company is enormous. Wall Street analysts are breaking out massive predictions in anticipation of the big August date. EF Hutton projects a 10x increase in share price, and major investors like Vanguard and BlackRock are already on board investing millions. You still have time - get an inside look at this biotech NOW. |
| Notice: Please understand that by opting out from future emails from this advertiser, you are transferring or Your privacy is important to us. Click here to see our Privacy Policy: https://www.zacks.com/privacy.php Zacks Investment Research |
Post a Comment
Post a Comment